The DOI matches its Crossref record; 398 of the 399 references it cites were found in a registry or an index.
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Abstract
This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence. The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in the hippocampus, dorsolateral prefrontal cortex, and dorsal thalamus. These findings have fostered the view of schizophrenia as a disorder of connectivity and of the synapse. Although attractive, such concepts are vague, and differentiating primary events from epiphenomena has been difficult. A way forward is provided by the recent identification of several putative susceptibility genes (including neuregulin, dysbindin, COMT, DISC1, RGS4, GRM3, and G72). We discuss the evidence for these and other genes, along with what is known of their expression profiles and biological roles in brain and how these may be altered in schizophrenia. The evidence for several of the genes is now strong. However, for none, with the likely exception of COMT, has a causative allele or the mechanism by which it predisposes to schizophrenia been identified. Nevertheless, we speculate that the genes may all converge functionally upon schizophrenia risk via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry. NMDA receptor-mediated glutamate transmission may be especially implicated, though there are also direct and indirect links to dopamine and GABA signalling. Hence, there is a correspondence between the putative roles of the genes at the molecular and synaptic levels and the existing understanding of the disorder at the neural systems level. Characterization of a core molecular pathway and a 'genetic cytoarchitecture' would be a profound advance in understanding schizophrenia, and may have equally significant therapeutic implications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the possible mechanisms that may be involved is dysfunction of the glutamatergic system (figure 1), which might affect synaptic plasticity and cortical microcircuitry, in particular (N-methyl-D-aspartate) NMDA-receptor signaling.10”
From Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies (2013) · cites this paper as [10]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Self-citationRecent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citationSchizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788
Flagged first, then by citations
1 of the 399 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Grossman MH, Littrel JB, Weinstein R, Szumlanski C, Weinshilboum R . Identification of the possible basis for inherited differences in human catechol-O-methyltransferase. Trans Neurosci Soc 1992; 18: 70.
- Straub RE, Egan MF, Hashimoto R, Matsumoto M, Weickert CS, Goldberg T et al. The schizophrenia susceptibility gene dysbindin (DTNBP1, 6p22.3): analysis of haplotypes, intermediate phenotypes, and alternative transcripts. Biol Psychiatry 2003; 53: 167S.
- Callicott JH, Pezeawas L, Egan MF, Hariri AR, Mattay VS, Goldberg TE et al. Genetic variationVariation in DISC-1 affects hippocampal structure and function associated with increased risk for schizophrenia and with normal hippocampal structure and function. (in review).
- Toro CT, Kasher PR, Deakin JFW . Altered D-serine metabolism in schizophrenia? A post-mortem study using Stanley Consortium brains [Abstract]. Schizophr Res 2004; 67(Suppl): 125.
Cited by
Sorted by citations
Items 301–400 of 1,003
Chu, E. M.-Y., Kolappan, M., Barnes, T. R. E., Joyce, E. M., & Ron, M. A. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.08.011 · Cited by 135
Delusions, illusions and hallucinations in epilepsy: 2. Complex phenomena and psychosis
Elliott, B., Joyce, E. M., & Shorvon, S. D. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.03.017 · Cited by 135
Glutamatergic Synapse Formation is Promoted by α7-Containing Nicotinic Acetylcholine Receptors
Lozada, A. F., Wang, X., Gounko, N. V., Massey, K. A., Duan, J., Liu, Z., & Berg, D. K. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6246-11.2012 · Cited by 134
Kuroda, K., Yamada, S., Tanaka, M., Iizuka, M., Yano, H., Mori, D., Tsuboi, D., Nishioka, T., Namba, T., Iizuka, Y., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr400 · Cited by 138
Association Analysis of 94 Candidate Genes and Schizophrenia-Related Endophenotypes
Greenwood, T. A., Light, G. A., Swerdlow, N. R., Radant, A. D., & BRAFF, D. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029630 · Cited by 134
Ehrlichman, R. S., Luminais, S. N., White, S., Rudnick, N. D., Ma, N., Dow, H. C., Kreibich, A. S., Abel, T. G., Brodkin, E. S., Hahn, C.-G., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.065 · Cited by 134
Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex
Guella, I., Sequeira, A., Rollins, B. L., Morgan, L., Torri, F., van Erp, T. G. M., Myers, R., Barchas, J. D., Schatzberg, A. F., Watson, S. J., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.021 · Cited by 132
Wong, E. H. F., Yocca, F. D., Smith, M. A., & Lee, C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000866 · Cited by 139
Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors
Kwon, O. B., Paredes, D., González, C. M., Neddens, J., Hernandez, L., Vullhorst, D., & Buonanno, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805722105 · Cited by 134
COMT genetic variation confers risk for psychotic and affective disorders: a case control study
Funke, B., Malhotra, A. K., Finn, C. T., Plocik, A. M., Lake, S. L., Lencz, T., DeRosse, P., Kane, J. M., & Kucherlapati, R. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-19 · Cited by 134
Brain Neuroplasticity in Healthy, Hyperactive and Psychotic Children: Insights from Neuroimaging
Rapoport, J. L., & Gogtay, N. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301553 · Cited by 132
Giakoumaki, S. G., Roussos, P., & Bitsios, P. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.82 · Cited by 136
Leliveld, S. R., Bader, V., Hendriks, P., Prikulis, I., Sajnani, G., Requena, J. R., & Korth, C. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5389-07.2008 · Cited by 133
PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia
Fatemi, S. H., King, D. P., Reutiman, T. J., Folsom, T. D., Laurence, J. A., Lee, S. S., Fan, Y.-T., Paciga, S. A., Conti, M., & Menniti, F. S. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.029 · Cited by 133
Tseng, K.-Y., Lewis, B. L., Lipska, B. K., & O’Donnell, P. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.012 · Cited by 132
G protein-coupled receptors in major psychiatric disorders
Catapano, L. A., & Manji, H. K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.025 · Cited by 133
Genetics and Epigenetics in Major Psychiatric Disorders
Abdolmaleky, H. M., Thiagalingam, S., & Wilcox, M. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505030-00002 · Cited by 134
Hope, S., Ueland, T., Steen, N. E., Dieset, I., Lorentzen, S., Berg, A. O., Agartz, I., Aukrust, P., & Andreassen, O. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.12.023 · Cited by 131
Turetsky, B. I., Greenwood, T. A., D, A. O. M., Radant, A. D., BRAFF, D. L., Cadenhead, K. S., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. E., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.018 · Cited by 131
Synaptic changes in the brain of subjects with schizophrenia
Faludi, G., & Mirnics, K. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.02.013 · Cited by 131
Peri-pubertal maturation after developmental disturbance: A model for psychosis onset in the rat
Pen, G. L., Gourévitch, R., Hazane, F., Hoareau, C., Jay, T. M., & Krebs, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.004 · Cited by 135
Walterfang, M., Wood, S. J., Velakoulis, D., & Pantelis, C. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.02.001 · Cited by 131
RETRACTED: Impaired Visual Cortical Plasticity in Schizophrenia
Çavuş, I., Reinhart, R. M. G., Roach, B. J., Gueorguieva, R., Teyler, T. J., Clapp, W. C., Ford, J. M., Krystal, J. H., & Mathalon, D. H. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.013 · Cited by 130
RetractedSánchez‐Blázquez, P., Rodríguez-Muñoz, M., & Garzón, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00169 · Cited by 131
Mcomish, C., Burrows, E., Howard, M., Scarr, E., Kim, D., Shin, H.-S., Dean, B., van den Buuse, M., & Hannan, A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002046 · Cited by 136
Diaz-Asper, C. M., Goldberg, T. E., Kolachana, B. S., Straub, R. E., Egan, M. F., & Weinberger, D. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.031 · Cited by 134
Self-citationDowning, A. M., Kinon, B. J., Millen, B. A., Zhang, L., Liu, L., Ma, M., Brenner, R., Rayle, T. J., Nisenbaum, L., Zhao, F., et al. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0351-3 · Cited by 129
SNAP‐25 in Neuropsychiatric Disorders
Corradini, I., Verderio, C., Sala, M., Wilson, M. C., & Matteoli, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03995.x · Cited by 128
Impact of interacting functional variants in COMT on regional gray matter volume in human brain
Honea, R., Verchinski, B. A., Pezawas, L., Kolachana, B. S., Callicott, J. H., Mattay, V. S., Weinberger, D. R., & Meyer-Lindenberg, A. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.064 · Cited by 128
Self-citationSchizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss
Bennett, M. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.003 · Cited by 129
Prenatal and postnatal maternal contributions in the infection model of schizophrenia
Meyer, U., Schwendener, S., Feldon, J., & Yee, B. K. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0419-5 · Cited by 128
Prediction and prevention of schizophrenia: what has been achieved and where to go next?
Klosterkötter, J., Schultze‐Lutter, F., Bechdolf, A., & Ruhrmann, S. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00044.x · Cited by 127
The Neuroproteomics of Schizophrenia
English, J. A., Pennington, K., Dunn, M. J., & Cotter, D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.031 · Cited by 127
Charych, E. I., Liu, F., Moss, S. J., & Brandon, N. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.027 · Cited by 130
Alberati, D., Moreau, J., Lengyel, J., Hauser, N., Mory, R., Borroni, E., Pinard, E., Knoflach, F., Schlotterbeck, G., Hainzl, D., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.008 · Cited by 127
Neuropathology of schizophrenia: A mini review
Iritani, S. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00798.x · Cited by 127
Zebrafish as a Model of Neurodevelopmental Disorders
de Abreu, M. S., Genário, R., Giacomini, A. C. V. V., Demin, K. A., Lakstygal, A. M., Amstislavskaya, T. G., Fontana, B. D., Parker, M. O., & Kalueff, A. V. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.034 · Cited by 132
Carter, C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.023 · Cited by 127
Gogtay, N., Lu, A., Leow, A. D., Klunder, A. D., Lee, A. D., Chavez, A., Greenstein, D., Giedd, J. N., Toga, A. W., Rapoport, J. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806485105 · Cited by 125
Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders
Penzes, P., Buonanno, A., Passafaro, M., Sala, C., & Sweet, R. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12261 · Cited by 125
Bakhshi, K., & Chance, S. A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.028 · Cited by 128
Benzel, I. M., Bansal, A. T., Browning, B. L., Galwey, N. W., Maycox, P. R., McGinnis, R. E., Smart, D. H., Clair, D. S., Yates, P., & Purvis, I. J. (2007) · Behavioral and Brain Functions · doi:10.1186/1744-9081-3-31 · Cited by 125
Nicotinic modulation of human auditory sensory memory: Evidence from mismatch negativity potentials
Baldeweg, T., WONG, D., & Stephan, K. E. (2005) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2005.07.014 · Cited by 125
Greenwood, T. A., Swerdlow, N. R., Gur, R. E., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. C., Lazzeroni, L. C., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020186 · Cited by 124
Price, G., Cercignani, M., Parker, G. J. M., Altmann, D. R., Barnes, T. R. E., Barker, G. J., Joyce, E. M., & Ron, M. A. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.12.019 · Cited by 123
Genetic Models of Sensorimotor Gating: Relevance to Neuropsychiatric Disorders
Powell, S. B., Weber, M., & Geyer, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_195 · Cited by 127
PDE inhibitors in psychiatry – future options for dementia, depression and schizophrenia?
Halene, T. B., & Siegel, S. J. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.023 · Cited by 122
Araud, T., Graw, S. L., Berger, R., Lee, M., Neveu, E., Bertrand, D., & Leonard, S. S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.018 · Cited by 128
Genetics of Smoking and Schizophrenia
Leonard, S. S., Mexal, S., & Freedman, R. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_05 · Cited by 124
Takao, K., Toyama, K., Nakanishi, K., Hattori, S., Takamura, H., Takeda, M., Miyakawa, T., & Hashimoto, R. (2008) · Molecular Brain · doi:10.1186/1756-6606-1-11 · Cited by 126
COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits
Winterer, G., Musso, F., Vučurević, G., Stoeter, P., Konrad, A., Seker, B., Gallinat, J., Dahmen, N., & Weinberger, D. R. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.05.058 · Cited by 123
Self-citationKostović, I., Judáš, M., & Sedmak, G. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.09.005 · Cited by 122
Mismatch Negativity: Translating the Potential
Todd, J., Harms, L. R., Schall, U., & Michie, P. T. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00171 · Cited by 123
Cerebral Asymmetry in Schizophrenia
Oertel‐Knöchel, V., & Linden, D. E. J. (2011) · The Neuroscientist · doi:10.1177/1073858410386493 · Cited by 129
Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders
Morozova, A. Y., Zorkina, Y., Abramova, O. V., Pavlova, O., Ka, P., Soloveva, K., Volkova, M., Alekseeva, P. A., Andryshchenko, A., Kostyuk, G. P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031217 · Cited by 132
Schmidt‐Kastner, R., van Os, J., Esquivel, G., Steinbusch, H. W. M., & Rutten, B. P. F. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.183 · Cited by 120
White matter tracts in first-episode psychosis: A DTI tractography study of the uncinate fasciculus
Price, G. W., Cercignani, M., Parker, G. J. M., Altmann, D. R., Barnes, T. R. E., Barker, G. J., Joyce, E. M., & Ron, M. A. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.09.012 · Cited by 120
Schizophrenia: New Pathological Insights and Therapies
Jarskog, L. F., Miyamoto, S., & Lieberman, J. A. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.060904.084114 · Cited by 119
Impact of Genetic Variant BDNF (Val66Met) on Brain Structure and Function
Chen, Z., Bath, K., McEwen, B., Hempstead, B., & Lee, F. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470751251.ch14 · Cited by 119
Harris, J. M., Moorhead, T. W. J., Miller, P., McIntosh, A. M., Bonnici, H. M., Owens, D. G. C., Johnstone, E. C., & Lawrie, S. M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.027 · Cited by 119
Todd, J., Michie, P. T., Schall, U., Ward, P. B., & Catts, S. V. (2011) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2011.10.003 · Cited by 127
Connectomic Intermediate Phenotypes for Psychiatric Disorders
Fornito, A., & Bullmore, E. T. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00032 · Cited by 121
Contributions of the d-serine pathway to schizophrenia
Labrie, V., Wong, A. H. C., & Roder, J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.030 · Cited by 121
Kantrowitz, J. T., & Javitt, D. C. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.3.6 · Cited by 120
The role of the cerebellum in schizophrenia: from cognition to molecular pathways
Yeganeh-Doost, P., Gruber, O., Falkai, P., & Schmitt, A. (2011) · Clinics · doi:10.1590/s1807-59322011001300009 · Cited by 118
Knöchel, C., Oertel‐Knöchel, V., Schönmeyer, R., Rotarska-Jagiela, A., van de Ven, V. G., Prvulovic, D., Haenschel, C., Uhlhaas, P. J., Pantel, J., Hampel, H. J., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.088 · Cited by 116
Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders
Tabarés‐Seisdedos, R., & Rubenstein, J. L. R. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3464 · Cited by 118
Cattane, N., Richetto, J., & Cattaneo, A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.001 · Cited by 129
McIntosh, A., Baig, B., Hall, J., Job, D., Whalley, H., Lymer, G., Moorhead, T. W., Owens, D. G., Miller, P., Porteous, D., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.020 · Cited by 124
Mudge, J., Miller, N., Khrebtukova, I., Lindquist, I. E., May, G. D., Huntley, J. J., Luo, S. J., Zhang, L., van Velkinburgh, J. C., Farmer, A. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003625 · Cited by 120
Human QKI, a new candidate gene for schizophrenia involved in myelination
Åberg, K. A., Saetre, P., Lindholm, E., Ekholm, B., Pettersson, U., Adolfsson, R., & JAZIN, E. E. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30243 · Cited by 116
Labrie, V., & Roder, J. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.08.002 · Cited by 118
Macdonald, D. S., Weerapura, M., Beazely, M. A., Martin, L. J., Czerwinski, W., Roder, J., Orser, B. A., & MacDonald, J. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3871-05.2005 · Cited by 115
Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia
Mohammadi, A., Rashidi, E., & Amooeian, V. G. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.036 · Cited by 119
Midbrain activation during pavlovian conditioning and delusional symptoms in schizophrenia
Romaniuk, L., Honey, G. D., King, J. R. L., Whalley, H. C., McIntosh, A. M., Levita, L., Hughes, M., Johnstone, E. C., Day, M., Lawrie, S. M., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.169 · Cited by 113
Identifying gene regulatory networks in schizophrenia
Potkin, S. G., Macciardi, F. M., Guffanti, G., Fallon, J. H., Wang, Q., Turner, J. A., Lakatos, A., Miles, M. F., Lander, A. D., Vawter, M. P., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.036 · Cited by 113
Baharnoori, M., Brake, W. G., & Srivastava, L. K. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.10.003 · Cited by 113
Ikeda, M., Hikita, T., Taya, S., Uraguchi‐Asaki, J., Toyo‐oka, K., Wynshaw-Boris, A. J., Ujike, H., Inada, T., Takao, K., Miyakawa, T., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn217 · Cited by 111
Hortopan, G. A., Dinday, M. T., & Baraban, S. C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1887-10.2010 · Cited by 114
Candidate genes for schizophrenia: A survey of association studies and gene ranking
Sun, J., Kuo, P., Riley, B. P., Kendler, K. S., & Zhao, Z. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30743 · Cited by 109
Horan, W. P., BRAFF, D. L., Nuechterlein, K. H., Sugar, C. A., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Greenwood, T. A., Gur, R. E., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.02.014 · Cited by 112
Predicting Drug Efficacy for Cognitive Deficits in Schizophrenia
Hagan, J. J. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi058 · Cited by 111
Çelik, M., Kalenderoğlu, A., Karadağ, A. S., Eğilmez, O. B., Almış, B. H., & Şimşek, A. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2015.10.006 · Cited by 109
Maternal vitamin D deficiency alters fetal brain development in the BALB/c mouse
Hawes, J. E., Tesic, D., Whitehouse, A., Zosky, G. R., Smith, J. T., & Wyrwoll, C. S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.008 · Cited by 107
Addington, A. M., Gornick, M. C., Shaw, P., Seal, J., Gogtay, N., GREENSTEIN, D. K., CLASEN, L. S., Coffey, M., Gochman, P., Long, R. T. L., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001906 · Cited by 110
Nuclear DISC1 regulates CRE-mediated gene transcription and sleep homeostasis in the fruit fly
Sawamura, N., Ando, T., Maruyama, Y., Fujimuro, M., Mochizuki, H., Honjo, K., Shimoda, M., Toda, H., Sawamura-Yamamoto, T., Makuch, L., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.101 · Cited by 107
Baldeweg, T., & Hirsch, S. R. (2015) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2014.03.008 · Cited by 108
Tracing the development of psychosis and its prevention: what can be learned from animal models
Piontkewitz, Y., Arad, M., & Weiner, I. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.019 · Cited by 108
Seshadri, S., Kamiya, A., Yokota, Y., Prikulis, I., Kano, S., Hayashi‐Takagi, A., Stanco, A., Eom, T.-Y., Rao, S., Ishizuka, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909284107 · Cited by 110
Genetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models
Chen, J., Lipska, B. K., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.024 · Cited by 108
Self-citationKempf, L., Nicodemus, K. K., Kolachana, B. S., Vakkalanka, R., Verchinski, B. A., Egan, M. F., Straub, R. E., Mattay, V. S., Callicott, J. H., Weinberger, D. R., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000252 · Cited by 108
Self-citationAlmond, S. L., Fradley, R. L., Armstrong, E. J., Heavens, R. B., Rutter, A. R., Newman, R. J., Chiu, C.-S., Konno, R., Hutson, P. H., & Brandon, N. J. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.05.003 · Cited by 108
Generation and Characterization of Rgs4 Mutant Mice
Grillet, N., Pattyn, A., Contet, C., Kieffer, B. L., Goridis, C., & Brunet, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4221-4228.2005 · Cited by 110
Evaluating the links between schizophrenia and sleep and circadian rhythm disruption
Pritchett, D., Wulff, K., Oliver, P. L., Bannerman, D. M., Davies, K. E., Harrison, P. J., Peirson, S. N., & Foster, F. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0817-8 · Cited by 111
Self-citationWhat genes are differentially expressed in individuals with schizophrenia? A systematic review
Merikangas, A. K., Shelly, M., Knighton, A., Kotler, N., Tanenbaum, N., & Almasy, L. A. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01420-7 · Cited by 110
Hattori, S., Murotani, T., Matsuzaki, S., Ishizuka, T., Kumamoto, N., Takeda, M., Tohyama, M., Yamatodani, A., Kunugi, H., & Hashimoto, R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.016 · Cited by 107
Selection of Reference Gene Expression in a Schizophrenia Brain Cohort
Weickert, C. S., Sheedy, D. L., Rothmond, D. A., Dedova, I. V., Fung, S. J., Garrick, T. M., Wong, J., Harding, A. J., Sivagnanansundaram, S., Hunt, C. E., et al. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903393662 · Cited by 110
Mouse models of genetic effects on cognition: Relevance to schizophrenia
Papaleo, F., Lipska, B. K., & Weinberger, D. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.025 · Cited by 107
Self-citationLyon, L., Saksida, L. M., & Bussey, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2536-5 · Cited by 107
Possible antipsychotic effects of minocycline in patients with schizophrenia
Miyaoka, T., Yasukawa, R., YASUDA, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.08.013 · Cited by 105
Metadata
- Authors
- Harrison, P. J., & Weinberger, D. R.
- Affiliations
- Warneford Hospital (GB)
- National Institutes of Health (US)
- Venue
- Molecular Psychiatry
- Published
- 2004-07-20
- Volume
- 10
- Issue
- 1
- Pages
- 40-68
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2071090720
- Cited by
- 2,020
- References
- 399
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 22 · 2023: 38 · 2022: 38 · 2021: 34 · 2020: 34 · 2019: 42 · 2018: 52 · 2017: 58 · 2016: 66 · 2015: 88 · 2014: 102 · 2013: 92 · 2012: 129
- FWCI
- 22.22
- Type
- journal article
- Language
- en
- Update notices
- erratum (2005-03-29)
- Open access
- closed
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, schizophrenia genetics, susceptibility genes, gene expression, synaptic plasticity, cortical microcircuitry, NMDA receptor, glutamatergic neurotransmission, dopamine signalling, GABA signalling, neuregulin, dysbindin, catechol-O-methyltransferase, DISC1, RGS4, GRM3, G72, hippocampus, dorsolateral prefrontal cortex, dorsal thalamus, brain connectivity
- MeSH terms
- Dysbindin, Brain, Carrier Proteins, Catechol O-Methyltransferase, Gene Expression Regulation, Humans, Schizophrenia, Genetic Predisposition to Disease, Neuregulin-1, Dystrophin-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review